FDA Clearance Tracker · P950019-S013
RAY TFC UNITE PRODUCT LINE
Last checked: Nov 20, 2026Latest source record: Jul 15, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Jul 15, 2003
Approved
Time to decision
152 days
Received Feb 13, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class II
The decision
- FDA number
- P950019-S013
- Device name
- RAY TFC UNITE PRODUCT LINE
- Applicant
- Stryker Spine
- Applicant location
- Allendale, NJ
- Received
- Feb 13, 2003
- Decided
- Jul 15, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Express GMP Supplement
- Original approval
- P950019
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.3080
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
APPROVAL FOR NEW MANUFACTURING FACILITIES FOR THE RAY TFC UNITE PRODUCT LINE. THE FACILITIES ARE LOCATED AT CENTERPULSE SPINE-TECH, MINNEAPOLIS, MINNESOTA AND BIOTEST LABORATORIES, INC., MINNEAPOLIS, MINNESOTA.
Source documents
Other decisions for Stryker Spine
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262061 · Decided Jul 17, 2026 · 29 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Cervical (ODP) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.